The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Share News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Solid State sees strong orders in security & defence

Wed, 06th Sep 2023 16:40

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Malin Corporation PLC - Dublin-based investor in life sciences companies - Estimated intrinsic equity value per share at June 30 was EUR6.25, compared to EUR9.34 at December 31 2022. Notes decrease was primarily attributable to the decline in the public market share price of Poseida in that period. Estimates intrinsic equity value per share at September 4 was EUR6.49, a 4% increase compared to June 30. This reflects a modest increase in the share price of Poseida following the announcement of a USD50 million strategic investment by Astellas in Poseida in August 2023.

----------

Beeks Financial Cloud Group PLC - Glasgow-based cloud computing and connectivity provider - Expects revenue for financial year 2023 to be over 20% higher than the year before, delivering underlying earnings before interest, tax, depreciation and amortisation growth of over 35% and underlying pretax profit growth of around 10%. Achieved a positive free cash flow position in the second half of the year in line with expectations, with net cash of GBP4.4 million, at the period end, compared to GBP3.4 million at the end of the first half. Adds the pipeline of opportunities for each of its offerings is significant and growing. Believes exchange cloud remains a potentially transformational opportunity.

----------

Solid State PLC - Redditch, England-based supplier & design-in manufacturer of computing, power, and communications products - Reports a strong start to the financial year across both divisions. Highlights particularly strong order intake in the security & defence sector, with the medical sector continuing to see good demand and new design opportunities. Continues to maintain a strong balance sheet which provides the business with advantageous commercial and competitive strength for working capital needs and M&A opportunities. Remains ambitious and continues to review acquisition opportunities and organic growth initiatives, with a view to meeting its new 2030 strategic objective of maintaining compound annual growth in total shareholder return in excess of 20%.

----------

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - States whilst it maintains a very strong order book, one of its leading products, the FoodPrint test, had some production challenges towards the end of the year which resulted in a drop in production yields. This resulted in a backlog in the fulfilment of some orders. New processes have now been brought in, boosting production, to successfully address the order backlog. Remains well-funded to deliver against strategic objectives and is implementing the final parts of the turnaround strategy outlined last year. Continues to vigorously pursue its substantial counterclaim for losses incurred towards the DHSC, as a direct result of its failure to licence the necessary intellectual property to permit the contract to move forward and their failure to notify the group of their inability to do so in a timely manner.

----------

M Winkworth PLC - London-based estate agent - Reports Winwkorth revenue in the six months to June 30 of GBP4.3 million, unchanged from the year before. Pretax profit of GBP811,000 was down 24% from GBP1.1 million with basic earnings per share of 4.33 pence, down 31% from 6.26p. Says gross revenue from its franchised network of GBP26.4 million, down 5% from GBP27.7 million the year before. Explains sales transactions in the first half of this year were constrained by a backdrop of rising interest rates, mitigated to a degree by the trend towards fixed term mortgages. Anticipates that the number of completions will firm up as the year progresses.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
30 May 2022 15:59

UK shareholder meetings calendar - next 7 days

Tuesday 31 May 
GYG PLCAGM
JTC PLCAGM
Lookers PLCAGM
McColl's Retail Group PLCAGM
Microlise Group PLCAGM
PageGroup PLCAGM
Petershill Partners PLCAGM
Sportech PLCAGM
Tekcapital PLCAGM
Wednesday 1 June  
Boku IncAGM
Parsley Box Group PLCAGM
One Media IP Group PLCAGM
United Oil & Gas PLCAGM
Flowtech Fluidpower PLCAGM
Dianomi PLCAGM
Honeycomb Investment Trust PLCGM re combination with Pollen Street Capital
East Imperial PLCAGM
Secure Income REIT PLCAGM
Public Policy Holding Co IncAGM
Thursday 2 June  
Clontarf Energy PLCGM re issue of new shares
HealthBeacon PLCAGM
Friday 3 June  
no events scheduled  
Monday 6 June  
Alphawave IP Group PLCAGM
Minoan Group PLCAGM
Omega Diagnostics Group PLCAGM
Sensyne Health PLCGM re strategic financing
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 12:31

IN BRIEF: Omega raises GBP2.0 million through placing and subscription

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Raises gross proceeds of GBP2.0 million via a placing of 50.0 million new shares and the issue of 90.0 million warrants at a price of 4.0 pence per share. Plans to use the proceeds to fund its CD4 business to divestment and provide additional working capital. Intends to dispose of the CD4 unit to focus solely on its Health & Nutrition business which contributes to the majority of its revenue. Plans to raise an additional GBP2.0 million by the issue of up to 49.9 million shares through an open offer. Expects its enlarged issued share capital to be 284.7 million shares, assuming full take-up of the open offer shares.

Read more
7 Apr 2022 14:30

IN BRIEF: Omega Diagnostics expects substantial annual revenue growth

Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Expects to report revenue of GBP12.3 million for the year ended March 31, up 41% from GBP8.7 million the year before. Says Covid-19-related revenue grew 53% to GBP2.6 million from GBP1.7 million. Expects ongoing Covid-related income to be minimal. Notes that net cash balance was GBP1.5 million at year-end and that it has an overdraft facility of GBP2.0 million which remains in place and unutilised. Continues to actively explore alternative options to generate additional funds.

Read more
7 Apr 2022 11:06

Omega Diagnostics FY revenues surge, sees 'minimal' ongoing Covid income

(Sharecast News) - Medical diagnostics company Omega said on Thursday that full-year revenues were expected to have surged in 2021 but cautioned that ongoing Covid-related income was now anticipated to be minimal.

Read more
11 Mar 2022 16:10

Omega's professional-use Covid test rejected by UK regulator

(Sharecast News) - Omega Diagnostics announced another disappointment for its Covid-19 tests on Friday, announcing that the UK Health Security Agency said its application for approval of the professional-use 'VISITECT' antigen test under the Coronavirus Test Device Approvals regulations (CTDA) was unsuccessful.

Read more
11 Mar 2022 11:15

AIM WINNERS & LOSERS: Omega Diagnostics Visitect not available in UK

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
7 Mar 2022 21:34

IN BRIEF: Omega completes conditional sale of manufacturing business

Omega Diagnostics Group PLC - Alva, Scotland-based medical diagnostics - Says it has completed the conditional sale agreement for Omega's diagnostic test kit manufacturing business and facility in Alva, Scotland. Agreement is with Accubio Ltd, a wholly-owned subsidiary of Zhejiang Orient Gene Biotech Co Ltd for a cash consideration of GBP1 million.

Read more
1 Mar 2022 20:32

TRADING UPDATES: Hutchmed in Macau boost; UP Global success in Germany

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Feb 2022 14:21

Omega selling Scotland factory after government Covid test plans collapse

(Sharecast News) - Medical diagnostics specialist Omega has signed a conditional sale and purchase agreement with Accubio, a wholly-owned subsidiary of Orient Gene, for the sale of its diagnostic test kit manufacturing business and facility in Alva, Scotland.

Read more
11 Feb 2022 11:31

Omega shares down on discounted fundraise; sells Alva facility

(Alliance News) - Omega Diagnostics Group PLC on Friday announced that it had begun a GBP7.0 million fundraise as well as sold its manufacturing business in Alva, Scotland.

Read more
10 Feb 2022 14:37

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

IN BRIEF: Omega Diagnostics confirms plan for GBP7 million fundraise

Read more
3 Feb 2022 15:39

Omega gets CE-marking for Covid-19 test, working on UK approval

(Sharecast News) - Medical diagnostics specialist Omega has successfully CE-marked its 'Visitect' Covid-19 antigen test for self-test use, it announced on Thursday.

Read more
3 Feb 2022 14:35

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

IN BRIEF: Omega Diagnostics shares up on CE mark for Covid-test

Read more
3 Feb 2022 11:00

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

AIM WINNERS & LOSERS: Omega Covid test gets CE mark; Creo revenue up

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.